Kodak CEO Jim Continenza is expected to testify in October about his purchase of Kodak stock last summer just prior to the announcement the company was getting a government loan to make ingredients for prescription drugs.
According to a filing with the Securities and Exchange Commission, Kodak will make Continenza and the General Counsel available to testify.
Kodak also is producing documents requested by state Attorney General Letitia James.
She is looking into possible violations of insider trading laws.